- Report
- July 2019
Global
From €961EUR$1,000USD£824GBP
The Symproic market is a subset of the pharmaceutical industry focused on the development and distribution of drugs used to treat addiction disorders. These drugs are designed to reduce cravings and withdrawal symptoms associated with substance abuse, and to help individuals maintain abstinence from drugs or alcohol. Symproic drugs are typically prescribed in combination with psychosocial interventions, such as counseling and support groups.
The Symproic market is highly competitive, with a range of companies offering different products. Some of the major players in the market include Alkermes, Orexo, Indivior, and Supernus Pharmaceuticals. Other companies, such as Allergan, Purdue Pharma, and Teva Pharmaceuticals, also offer Symproic drugs. Show Less Read more